825
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

A Randomized, Controlled Trial of the Efficacy of an Interoceptive Exposure-Based CBT for Treatment-Refractory Outpatients with Opioid Dependence

, Ph.D., , Ph.D., , Ph.D., , Ph.D., , Ph.D., , Ph.D., , Ph.D. & , M.D. show all

REFERENCES

  • Amato, L.; Minozzi, S.; Davoli, M. & Vecchi, S. 2011. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Systematic Review 10: CD004147.
  • Baker, A.; Bucci, S.; Lewin, T.J.; Richmond, R. & Carr, V.J. 2005. Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research 134 (3): 241–250.
  • Basden, S.L.D. 2010. Acquisition and extinction in a substance dependent sample: A de novo fear conditioning study. Doctoral thesis, Boston University, Boston, MA.
  • Bornovalova, M.A.; Gratz, K.L.; Daughters, S.B.; Hunt, E.D. & Lejuez, C.W. 2012. Initial RCT of a distress tolerance treatment for individuals with substance use disorders. Drug Alcohol Dependence 122 (1–2): 70–76.
  • Brands, B.; Blake, J.; Sproule, B.; Gourlay, D. & Busto, U. 2004. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence 73 (2): 199–207.
  • Brown, R.A.; Palm, K.M.; Strong, D.R.; Lejuez, C.W.; Kahler, C.W.; Zvolensky, M.J.; et al. 2008. Distress tolerance treatment for early-lapse smokers: Rationale, program description, and preliminary findings. Behavior Modification 32 (3): 302–332.
  • Carroll, K.M.; Easton, C.J.; Nich, C.; Hunkele, K.A.; Neavins, T.M.; Sinha, R.; Ford, H.L.; Vitolo, S.A.; Doebrick, C.A. & Rounsaville, B.J. 2006. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. Journal of Consulting and Clinical Psychology 7 (5): 955–966.
  • Carroll, K.M.; Rounsaville, B.J.; Nich, C.; Gordon, L.T.; Wirtz, P.W. & Gawin, F.H. 1994. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: Delayed emergence of psychotherapy effects. Archives of General Psychiatry 51 (12): 989–997.
  • Childress, A.R.; Ehrman, R.; McLellan, A.T.; MacRae, J.; Natale, M. & O’Brien, C.P. 1994. Can induced moods trigger drug-related responses in opiate abuse patients? Journal of Substance Abuse Treatment 11 (1): 17–23.
  • Conklin, C.A. & Tiffany, S.T. 2002. Applying extinction research and theory to cue-exposure addiction treatments. Addiction 97 (2): 155–167.
  • Cooper, M.L.; Russell, M.; Skinner, M.B. & Windle, M. 1992. Development and validation of a three dimensional measure of drinking motives. Psychological Assessment 4: 123–132.
  • Crits-Christoph, P.; Siqueland, L.; Blaine, J.; Frank, A.; Luborsky, L.; Onken, L.S.; Muenz, L. R.; Thase, M.E.; Weiss, R.D.; Gastfriend, D.R.; et al. 1999. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Archives of General Psychiatry 56 (6): 493–502.
  • Dekimpe, M.G.; Van de Gucht, L.M.; Hanssens, D.M. & Keiko, I. 1998. Long-run abstinence after treatment for narcotics abuse: What are the odds? Management Science 44: 1478–1492.
  • Domingo-Salvany, A.; Brugal, M.T.; Barrio, G.; Gonzalez-Saiz, F.; Bravo, M.J. & de la Fuente, L. 2010. Gender differences in health related quality of life of young heroin users. Health and Quality of Life Outcomes 8: 145.
  • Dutra, L.; Stathopoulou, G.; Basden, S.L.; Leyro, T.M.; Power, M.B. & Otto, M.W. 2008. A meta-analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry 165 (2): 179–187.
  • First, M.B.; Spitzer, R.L.; Gibbon, M. & Williams, J.B.W. 1996. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, Version 2.0 ). New York: Biometrics Research Department, New York State Psychiatric Institute.
  • Games, P.A. 1984. Data transformations, power, and skew: A rebuttal to Levine and Dunlap. Psychological Bulletin 95: 345–347.
  • Greenfield, S.F.; Brooks, A.J.; Gordon, S.M.; Green, C.A.; Kropp, F. et al. 2007. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Abuse 86 (1): 1–21.
  • Hearon, B.A.; Calkins, A.W.; Halperin, D.M.; McHugh, R.K.; Murray, H.W. & Otto, M.W. 2011. Anxiety sensitivity and illicit sedative use among opiate-dependent women and men. American Journal of Drug and Alcohol Abuse 37 (1): 43–47.
  • Hser, Y.I.; Hoffman, V.; Grella, C.E. & Anglin, M.D. 2001. A 33-year follow-up of narcotics addicts. Archives of General Psychiatry 58 (5): 503–508.
  • Jimenez-Trevino, L.; Saiz, P.A.; Garcia-Portilla, M.P.; Diaz-Mesa, E.M.; Sanchez- Lasheras, F.; et al. 2011. A 25-year follow-up of patients admitted to methadone maintenance for the first time: Mortality and gender differences. Addictive Behaviors 36 (12): 1184–1190.
  • Johnson, K.; Mullin, J.L.; Marshall, E.C.; Bonn-Miller, M.O. & Zvolensky, M. 2010. Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence. American Journal of Addiction 19 (3): 277–82.
  • Kay-Lambkin, F.J.; Baker, A.L.; Kelly, B. & Lewin, T.J. 2011. Clinician-assisted computerized versus therapist-delivered treatment for depressive and addictive disorders: S randomized controlled trial. The Medical Journal of Australia 195 (3): 44–50.
  • Kraemer, H.C.; Wilson, G.T.; Fairburn, C.G. & Agras, W.S. 2002. Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 59 (10): 877–883.
  • Lejuez, C.W.; Zvolensky, M.J.; Daughters, S.B.; Bornovalova, M.A.; Paulson, A.; Tull, M.T.; Ettinger, K. & Otto, M.W. 2008. Anxiety sensitivity: A unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behavior Research and Therapy 46 (7): 811–818.
  • Marlatt, G.A. & Gordon, J.R. 1980. Determinants of relapse: Implications for the maintenance of behavior change. In: P. Davidson ( Ed. ) Behavioral Medicine: Changing Health Life Styles. New York: Brunner/Mazel.
  • McHugh, R.K.; Devito, E.E.; Dodd, D.; Carroll, K.M.; Potter, J.S.; et al. 2013a. Gender differences in a clinical trial for prescription opioid dependence. Journal of Substance Abuse Treatment 45 (1): 38–43.
  • McHugh, R.K. ; Murray, H.W.; Hearon, B.A.; Pratt, E.M.; Pollack, M.H.; Safren, S.A. & Otto, M.W. 2013b. Predictors of dropout from psychosocial treatment in opioid-dependent outpatients. American Journal on Addictions 22 (1): 18–22.
  • McHugh, R.K. & Otto, M.W. 2011. Domain-general and domain-specific strategies for the assessment of distress intolerance. Psychology of Addictive Behaviors 25 (4): 745–749.
  • McLellan, A.T.; Luborsky, L.; O’Brien, C.P. & Woody, G.E. 1980. An improved evaluation instrument for substance abuse patients: The Addition Severity Index. Journal of Nervous and Mental Diseases 168 (1): 26–33.
  • Mercer, D.E. & Woody, G.E. 1999. Individual Drug Counseling (NIH Pub. No. 99–4380). Washington, DC: U.S. Government Printing Office.
  • Monti, P.M.; Rohsenow, D.J.; Colby, S.M. & Abrams, D.B. 1995. Smoking among alcoholics during and after treatment: Implications for models, treatment strategies, and policy. In J. B. Ferig ( Ed. ) Alcohol and Tobacco: From Basic Science to Policy. Bethesda: National Institute of Alcohol Abuse and Addiction.
  • Mueser, K.T.; Nishith, P.; Tracy, JI.; DeGirolamo, J. & Molinaro, M. 1995. Expectations and motives for substance use in schizophrenia. Schizophrenia Bulletin 21(3): 367–378.
  • Nurco, D.N.; Kinlock, T.W.; Hanlon, T.E. & Ball, J.C. 1988. Nonnarcotic drug use over an addiction career—a study of heroin addicts in Baltimore and New York City. Comprehensive Psychiatry 29 (5): 450–459.
  • O’Brien, C.P.; Childress, A.R.; McLellan, T. & Ehrman, R. 1990. Integrating systematic cue exposure with standard treatment in recovering drug dependent patients. Addictive Behaviors 15 (4): 355–365.
  • O’Connell, K.A. & Martin, E.J. 1987. Highly tempting situations associated with abstinence, temporary lapse, and relapse among participants in smoking cessation programs. Journal of Consulting and Clinical Psychology 55 (3): 367–371.
  • Otto, M.W.; McHugh, R.K.; Simon, N.M.; Farach, F.J.; Worthington, J.J. & Pollack, M.H. 2010. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behavior Research and Therapy 48 (8): 720–727.
  • Otto, M.W.; O’Cleirigh, C.M. & Pollack, M.H. 2007. Attending to emotional cues for drug use: Bridging the gap between clinic and home behavior. NIDA Science and Practice Perspectives April: 48–55.
  • Otto, M.W.; Powers, M.B. & Fischmann, D. 2005. Emotional exposure in the treatment of substance use disorders: Conceptual model, evidence, and future directions. Clinical Psychology Review 25 (6): 824–39.
  • Ouimette, P.; Read, J.P.; Wade, M. & Tirone, V. 2010. Modeling associations between posttraumatic stress symptoms and substance use. Addictive Behaviors 35 (1): 64–67.
  • Perkins, K.A.; Karelitz, J.L.; Giedgowd, G.E. & Conklin, C.A. 2013. Negative mood effects on craving to smoke in women versus men. Addictive Behaviors 38 (2): 1527–1531.
  • Peterson, R.A. & Reiss, S. 1992. Anxiety Sensitivity Index Revised Test Manual. Palos Heights, IL: International Diagnostic Systems.
  • Pollack, M.H.; Penava, S.A.; Bolton, E.; Worthington, J.J.; Allen, G.L.; Farach, F.J. & Otto, M.W. 2002. A novel cognitive-behavioral approach for treatment-resistant drug dependence. Journal of Substance Abuse Treatment 23 (4): 335–342.
  • Rawson, R.A.; Huber, A.; McCann, M.J.; Shoptaw, S.; Farabee, D.; Reiber, C. & Ling, W. 2002. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance for cocaine dependence. Archives of General Psychiatry 59 (9): 817–824.
  • Reiss, S.; Peterson, R.A.; Gursky, M. & McNally, R.J. 1986. Anxiety sensitivity, anxiety frequency, and the prediction of fearfulness. Behaviour Research and Therapy 24 (1): 1–8.
  • Robbins, S.J.; Ehrman, R.N.; Childress, A.R.; Cornish, J.W. & O’Brien, C.P. 2000. Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. Drug and Alcohol Dependence 59 (1): 33–42.
  • Rohsenow, J.H. & Monti, P.M. 1999. Does urge to drink predict relapse after treatment? Alcohol Research and Health 23 (3): 225–232.
  • Rubonis, A.V.; Colby, S.M.; Monti, P.M.; Rohsenow, D.T.; Gulliver, S.B. & Sirota, A.D. 1994. Alcohol cue reactivity and mood induction in male and female alcoholics. Journal of Studies on Alcohol 55 (4): 487–494.
  • San, L.; Cami, J.; Peri, J.M.; Mata, R. & Porta, M. 1990. Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: A controlled trial. British Journal of Addiction 85 (1): 141–147.
  • Shand, F.L.; Degenhardt, L.; Slade, T. & Nelson, E.C. 2011. Sex differences amongst dependent heroin users: Histories, clinical characteristics and predictors of other substance dependence. Addictive Behaviors 36 (1–2): 27–36.
  • Sherman, J.E.; Zinser, M.C.; Sideroff, S.I. & Baker, T.B. 1989. Subjective dimensions of heroin urges: Influence of heroin-related and affectively negative stimuli. Addictive Behaviors 14 (6): 611–623.
  • Siegel, S. 2005. Two views of the addiction elephant: A comment on McSweeney, Murphy, and Kowal. Experimental and Clinical Psychopharmacology 13 (3): 190– 193.
  • Smits, J.A.; Berry, A.C.; Tart, C.D. & Powers, M.B. 2008. The efficacy of cognitive-behavioral interventions for reducing anxiety sensitivity: A meta-analytic review. Behavior Research and Therapy 46 (9):1047–54.
  • Stewart, S.H.; Karp, J.; Pihl, R.O. & Peterson, R.A. 1997. Anxiety sensitivity and self- reported reasons for drug use. Journal of Substance Abuse 9: 223–240.
  • Stitzer, M.L.; Iguchi, M.Y. & Felch, L.J. 1992. Contingent take-home incentive: Effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology 60 (6): 927–934.
  • Strain, E.C. 2002. Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. The Clinical Journal of Pain 18: 14–27.
  • Tull, M.T.; Schulzinger, D.; Schmidt, N.B.; Zvolensky, M.J. & Lejuez, C.W. 2007. Development and initial examination of a brief intervention for heightened anxiety sensitivity among heroin users. Behavior Modification 31 (2): 220–242.
  • van den Brink, W. & Haasen, C. 2006. Evidenced-based treatment of opioid-dependent patients. Canadian Journal of Psychiatry 51 (10): 635–646.
  • Veilleux, J.C.; Colvin, P.J.; Anderson, J.; York, C. & Heinz, A.J. 2010. A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychology Review 30 (2): 155–166.
  • Weiss, R.D.; Potter, J.S.; Fiellin, D.A.; Byrne, M.; Connery, H.S.; Dickinson, W.; et al. 2011. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry 68 (12): 1238–1246.
  • Wikler, A. 1965. Conditioning factors in opiate addiction and relapse. In: D.I. Wilner and G.G. Kassenbaum, ( Eds. ) Narcotics, pp. 85–100. New York: McGraw-Hill.
  • Williamson, A.; Darke, S.; Ross, J. & Teeson, M. 2009. Changes and predictors of change in the physical health status of heroin users over 24 months. Addiction 104 (3): 465–470.
  • Woody, G.E.; McLellan, A.T.; Luborsky, L. & O’Brien, C.P. 1990. Psychotherapy and counseling for methadone-maintained opiate addicts: Results of research studies. NIDA Research Monograph 104: 9–23.
  • Zvolensky, M.J.; Eifert, G.H. & Lejuez, C.W. 2001. Emotional control during recurrent 20% carbon dioxide-enriched air induction: Relation to individual difference variables. Emotion 1 (2): 148–165.
  • Zywiak, W.; Connors, G.J.; Maisto, S. & Westerberg, V.S. 1996. Section IIA. Replication and extension of Marlatt’s taxonomy: Relapse research and the reasons for drinking questionnaire: A factor analysis of Marlatt’s relapse taxonomy. Addiction 91: s121–s130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.